Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2

New SARS-CoV-2 variants of concern and waning immunity demonstrate the need for a quick and simple prophylactic agent to prevent infection. Low molecular weight heparins (LMWH) are potent inhibitors of SARS-CoV-2 binding and infection in vitro. The airways are a major route for infection and therefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Eder, Julia, Bermejo-Jambrina, Marta, Vlaming, Killian E., Kaptein, Tanja M., Zaderer, Viktoria, Kemper, E. Marleen, Wilflingseder, Doris, Reitsma, Sietze, de Bree, Godelieve J., Cohn, Danny M., Geijtenbeek, Teunis B. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765130/
https://www.ncbi.nlm.nih.gov/pubmed/36326251
http://dx.doi.org/10.1128/mbio.02558-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765130/
https://www.ncbi.nlm.nih.gov/pubmed/36326251
http://dx.doi.org/10.1128/mbio.02558-22

Ejemplares similares